0709 203000 - Nairobi 0709 983000 - Kilifi
0709 203000 - NRB 0709 983000 - Kilifi
0709 203000 - NRB | 0709 983000 - Kilifi

Publications

Back Home

Biosciences


830 results

Longitudinal Epidemiology and Variant Dynamics of SARS-CoV-2 in Coastal Kenya (2020-2025): Clinical Features and Wave Patterns.Lambisia AW Nyiro J Githinji G Katama EN Moraa E Mwita JM Mutunga M Maina G Bejon P Phan MVT Cotten M Dellicour S Ochola-Oyier LI Sande C Holmes EC Nyagwange J Agoti CN
Open Forum Infect Dis, (2026). 13:ofag084

B and T cell responses to pre-erythrocytic R21/Matrix-M and blood-stage RH5.1/Matrix-M malaria vaccines in endemic settings.Bundi CK Mu├▒oz O Kibwana E Bellamy D Stockdale L Barrett JR McHugh K Mtaka I Kalinga W Kimani D Nyamako L Keter K Ogwang R Hill AVS Bejon P Hamaluba M Silk SE Minassian AM Draper SJ Olotu AI Kapulu MC Ewer KJ Nielsen CM
Front Immunol, (2026). 17:1743327

Prevalence, spatial and temporal distribution of tungiasis in the Kilifi Health and Demographic Surveillance System (KHDSS) in Kenya.Ouma N Muchiri SK Nyundo C Walumbe D Nyaguara A Maia M Adetifa I Orindi B Bejon P Fillinger U Elson L
BMJ Glob Health, (2026). 11:

Variation in antiviral immunity and inflammation pathways precedes HIV-1 infection in a high-risk African cohort.Kioko M Mwangi S Fwambah L Hassan AS Blackard JT Bejon P Sanders EJ Ndung'u T Nduati EW Abdi AI
J Clin Invest, (2026). :

Evolving patterns of antimalarial drug resistance markers in symptomatic infections in Kenya, 2013-2022.Magudha J Ndwiga L Akinyi MY Wamae K Osoti V Kandie R Kiplagat R Keitany K Bargul JL Akala HM Ochola-Oyier LI
Parasit Vectors, (2026). 19:

Pre-COVID-19 ex vivo cross-reactive IFN-gamma cellular response to SARS-CoV-2 spike overlapping peptides is more prevalent among Kenyan compared to Swedish adults.Wanjiku P Orindi B Mwacharo J Chemweno J Karanja HK Kronsteiner B Kai O Wright D Ochola-Oyier LI Sundling C Dunachie S Warimwe GM Farnert A Bejon P Ndungu FM Nduati EW
BMC Infect Dis, (2026). 26:174

Low-dose yellow fever vaccination in infants: a randomised, double-blind, non-inferiority trial.Kimathi D Juan-Giner A Bob NS Orindi B Namulwana ML Diatta A Cheruiyot S Fall G Dia M Hamaluba MM Nyehangane D Karanja HK Gitonga JN Mugo D Omuoyo DO Hussein M Oloo E Kamau N Wafula J Bendera J Silvester N Mwavita J Joshua M Thuranira JM Agababyona C Ngetsa C Aisha N Moki F Buluku T Munene M Mwanga-Amumpaire J Lutwama J Kayiwa J Kamaara E Barrett AD Kaleebu P Bejon P Sall AA Grais RF Warimwe GM
Lancet, (2026). 407:497-504

Malaria vaccine protection against intradermal or venous parasites: a randomized phase 2b human challenge trial.Kapulu MC Orenge F Kimani D Kibwana E Kibet H Mutahi M Datoo MS Bellamy D Musembi J Ngoto O Rashid H Akinyi S Mwatasa MH Nyamako L Keter K Gatheru R Mutiso A Musyoki J Mwacharo J Abebe Y James ER Billingsley PF Ngetsa C Mosobo M Makale J Tawa B Wamae K Ochola-Oyier LI Lawrie A Ramos-Lopez F Roberts R Richie TL Sim BKL Hoffman SL Ewer KJ Hill AVS Hamaluba M Bejon P
Nat Med, (2026). 32:178-185

Community Experiences and Perceptions of the Broad One Health Endectocide-Based Malaria Intervention in Africa Trial of Ivermectin Mass Drug Administration: A Longitudinal Qualitative Study in Kwale County, Kenya.Wangari W Onyango T Kazungu K Nuru K Kasiwa L Chaccour C Rabinovich NR Mwangangi J Maia M Jones C
Am J Trop Med Hyg, (2026). 114:72-84

Characterizing Plasmodium falciparum genetic diversity and complexity of infections in clinical malaria infections in Western and Coastal Kenya using the poly-alpha microsatellite marker.Abade NA Mgawe C Ndwiga L Kimenyi KM Ochola-Oyier LI
Malar J, (2025). 24:452

Inflammation impairs post-hospital discharge growth among children hospitalised with acute illness in sub-Saharan Africa and south Asia.Njunge JM Mudibo EO Bogaert J Orindi B Sande CJ Bourdon C Tigoi C Ngari MM Ngao N Omer E Gumbi W Musyimi R Timbwa M Mwaringa S Gwela A Thitiri J Mupere E Lancioni CL Gonzales GB Singa BO Mbale E Voskuijl WP Denno DM Diallo AH Bamouni RM Chisti MJ Shahid Asmsb Ahmed T Saleem AF Ali SA Uhlig HH Tickell KD Bandsma RHJ Walson JL Berkley JA
Nat Commun, (2025). 16:10788

Plasma lipopolysaccharide levels predict mortality in acutely ill children in Low- and Middle-Income Countries.Allen CAD Ghate A Njunge JM Gartner L Diallo AH Lancioni C Mupere E Gwela A Tigoi C Singa BO Gumbi W Bandsma RHJ Voskuijl WP Chisti MJ Ahmed T Shahid Asmsb Ahmed D Saleem A Kazi Z Jones K Tickell KD Walson JL Berkley JA Uhlig HH
Nat Commun, (2025). 16:10787

Corrigendum to 'Volatile pyrethroid spatial repellents for preventing mosquito bites: a systematic review and meta-analysis' EBioMedicine Volatile pyrethroid spatial repellents for preventing mosquito bites: a systematic review and meta-analysis 119 (2025) 105891/10.1016/j.ebiom.2025.105891 Sep: 119: 105891.Chen I Miller SL Msellemu D Lugenge AG Swai JK Achee N Andres M Bibbs CS Chareonviriyaphap T Charlwood JD Devine G Elman N Fillinger U Flores-Mendoza C Gibson S Govella N Gowelo S Horstmann S Kawada H Kline D Lloyd A Lobo NF Maia MF Mmbando A Moreno-Gomez M Morrison AC Mponzi W Mwanga EP Njoroge M Ogoma SB Okumu FO Opiyo M Oumbouke WA Paliga J Pongsiri A Ponlawat A Saeaung M Salazar F Sangoro O Stevenson JC Sukkanon C Syafruddin D Tambwe MM Tangena JA Vajda EA Vazquez-Prokopec G Wagman JM Yan C Allen IE Moore SJ
EBioMedicine, (2025). 122:106049

Pf8: an open dataset of Plasmodium falciparum genome variation in 33,325 worldwide samples.Malaria Genomic Epidemiology Network Abdel Hamid MM Abdelraheem MH Acheampong DO Adam I Aide P Ajibaye O Ali M Almagro-Garcia J Amambua-Ngwa A Amenga-Etego L Aniebo I Aninagyei E Ansah F Apinjoh TO Ariani CV Auburn S Awandare GA Balmer A Bejon P Boene S Bwire G Candrinho B Chidimatembue A Chindavongsa K Comiche K Conway D Dara A Diakite M Djimde A Dondorp A Doumbia S Drury E Fanello CA Ferdig M Figueroa K Gamboa D Golassa L Goncalves S Guindo MDA Hamaluba M Hanboonkunupakarn B Howe K Hussien M Imwong M Ishengoma D Jeans J Kabaghe A Kamuhabwa A Kindermans JM Konate DS Kwiatkowski DP Lee C Lee SK Lee SJ Ley B Llanos-Cuentas A Marfurt J Matambisso G Maude RR Maude RJ Mayor A Mayxay M Maiga-Ascofare O McCann RS Miles A Miotto O Mohamed AO Morang'a CM Murie K Ngasala BE Nguyen TN Nolasco O Nosten F Noviyanti R O'Connor I Oboh M Ochola-Oyier LI Olufunke Falade C Olukosi A Olumide A Olusola FI Onyamboko MA Oriero EC Oyibo WA Pannebaker D Pearson RD Phiri K van der Pluijm RW Price RN Quang HH Rajkumar Devaraju V Randrianarivelojosia M Ranford-Cartwright L Rayner JC Rovira-Vallbona E Rowlands K Ruano-Rubio V Sanchez JF Saute F Shettima S da Silva C Simpson VJ Suddaby S Takken W Thu AM Toure M Unlu E Valdivia HO van Vugt M Waithira N Wellems T Wendler J White N Wuendrich Ogidan R
Wellcome Open Res, (2025). 10:325

A scoping review of antimalarial drug resistance markers in Kenya (1987-2022): toward a National Surveillance Framework and Data Repository.Wamae K Magudha J Asiimwe E Kimani K Kandie R Keitany K Snow RW Ochola-Oyier LI
Malar J, (2025). 24:413

Serial cross-sectional school surveys identifies C469Y, P553L, R561H and A675V kelch 13 mutations associated with artemisinin resistance in Western Kenya.Osoti V Wamae K Musau MM Magudha JB Ndwiga L Gichuki PM Okoyo C Rosebella K Mahugu S Aricha S Kandie R Keitany K Kepha S Mwandawiro C Bejon P Snow RW Ochola-Oyier LI
Sci Rep, (2025). 15:38303

MALDI-TOF MS for malaria vector surveillance: A cost-comparison analysis using a decision-tree approach.Karisa J Rist C Tuwei M Ominde K Bartilol B Ondieki Z Musani H Wanjiku C Mwangangi J Mbogo C Rono M Bejon P Maia M
PLoS One, (2025). 20:e0335764

A Pragmatic Trial of Glucocorticoids for Community-Acquired Pneumonia.Lucinde RK Gathuri H Mwaniki P Orindi B Otieno EO Mwakio S Mulemi L Isaaka L Shangala J Saisi M Isinde E Oginga IN Wachira AW Manuthu E Kariuki H Asaava P Nyikuli J Wekesa C Otedo A Bosire H Okoth SB Ongalo W Mukabi DM Lusamba W Muthui B Adembesa I Mithi C Sood M Aliyan NA Gituma B Matiko MG Omondi CA Ombajo LA Kirui N Ochola L Abdi AI Kagucia EW English M Hamaluba M Ochola-Oyier I Kamuya D Bejon P Barasa E Agweyu A Akech S Etyang AO
N Engl J Med, (2025). 393:2187-2197

Validation of high-throughput oxford nanopore technology for HIV-1 transmitted/founder virus identification.Byamukama D Ndekezi C Omara D Nakyanzi A Natwijuka F Kato F Mugaba S Kimuda MP Kapaata A Nduati E Kaleebu P Balinda SN
Int J Infect Dis, (2025). 161:108138

Genetic isolation drives divergent insecticide resistance between coastal and western Kenya Anopheles funestus populations.Polo B Milanoi S Omoke DN Odhiambo CA Nagi SC Nwezeobi J Makunin AI Bodde M Abong'o B Midega J Kamau L Onguru D Miles A Lawniczak M Ochomo E
Sci Rep, (2025). 15:35920